OncoSil Medical (ASX: OSL) has marked a critical milestone by successfully treating pancreatic cancer in Europe with its flagship OncoSil device. The surgery, carried out at Madrid's Hospital Universitario de Fuenlabrada, is a significant step forward in localized cancer therapy. As OncoSil advances in the area, investors and healthcare enthusiasts see encouraging developments that position the firm as a vital participant in breakthrough cancer treatment solutions.